Keywords: UK, NICE, GlaxoSmithKline, Trobalt, The Medicines Company, Angiox, Epilepsy, Myocardial infarction

Positive draft guidance from UK’s NICE for GSK’s Trobalt and TMC’s Angiox

Article | 20 June 2011

Print This

The UK’s drug watchdog body the National Institute for Health and Clinical Excellence (NICE) last week issued draft ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in